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Molecular basis of Celmer’s rules: the role of two ketoreductase 
domains in the control of chirality by the erythromycin modular 
polyketide synthase 
In&s E Holzbaurl, Rebecca C Harris’, Matthew Bycroft’, Jesus Cartes*, 
Christian Bisang*, James Staunton l, Brian AM Rudd3 and Peter F Leadlay* 
Background: Polyketides are compounds that possess medically significant 
activities. The modular nature of the polyketide synthase (PKS) multienzymes 
has generated interest in bioengineering new PKSs. Rational design of novel 
PKSs, however, requires a greater understanding of the stereocontrol 
mechanisms that operate in natural PKS modules. 
Results: The N-acetyl cysteamine (NAC) thioester derivative of the natural 
P-keto diketide intermediate was incubated with DEBSl -TE, a derivative of the 
erythromycin PKS that contains only modules 1 and 2. The reduction products 
of the two ketoreductase (KR) domains of DEBSl -TE were a mixture of the 
(2S,3R) and (2R,3S) isomers of the corresponding P-hydroxy diketide NAC 
thioesters. Repeating the incubation using a DEBSl -TE mutant that only 
contains KRl produced only the (2S,3R) isomer. 
Conclusions: In contrast with earlier results, KRl selects only the (2s) isomer 
and reduces it stereospecifically to the (2S,3R)-3-hydroxy-2-methyl acyl product. 
The KR domain of module 1 controls the stereochemical outcome at both methyl- 
and hydroxyl-bearing chiral centres in the hydroxy diketide intermediate. Earlier 
work showed that the normal enzyme-bound ketoester generated in module 2 is 
not epimerised, however. The stereochemistry at C-2 is therefore established by a 
condensation reaction that exclusively gives the (Pm-ketoester, and the stereo- 
chemistry at C-3 by reduction of the keto group. Two different mechanisms of 
stereochemical control, therefore, operate in modules 1 and 2 of the erythromycin 
PKS. These results should provide a more rational basis for designing hybrid 
PKSs to generate altered stereochemistry in polyketide products. 
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Introduction 
Macrolide polyketides, such as erythromycin A, have mul- 
tiple chiral centres. The mechanism of stereochemical 
control in polyketide biosynthesis is, therefore, an impor- 
tant and challenging problem. Interest has been increased 
recently by many examples of bioengineering in which 
the synthase responsible for assembly of the macrolide 
core has been altered to produce specific alterations in the 
structure of the natural product [14]. Recently, stereo- 
chemistry has also been altered by the replacement of 
ketoreductase (KR) domains [S]. 
The rapid progress in experiments designed to alter struc- 
ture has been based on the modular nature of the polyke- 
tide synthases responsible for chain assembly, which first 
became apparent with the sequencing of the erythromycin 
polyketide synthase (PKS) [6,7]. The genes responsible for 
the erythromycin PKS code for three giant multifunctional 
proteins in which there are multiple active sites (domains) 
that show strong homology to the various enzymes known 
to be responsible for fatty acid biosynthesis. There are six 
sets or ‘modules’ of collaborating domains with a different 
module catalysing each cycle of chain extension (Figure 1). 
Each module contains three core domains that are essen- 
tial for C-C bond formation: a ketosynthase (KS) domain 
and an acyl carrier protein (ACP). which cooperate to 
extend the chain by catalysing the decarboxylative con- 
densation of a methyl-malonyl unit with a pre-existing 
acyl chain, and an acyltransferase domain (AT), which 
loads the malonate extender unit onto the ACP. 4 module 
can also contain one or more reductive domains to modify 
the ketone group in the initially formed keto ester. 
The full set of reductive steps follow the course shown 
in Figure 2. The keto group is first reduced by NADPH 
in a reaction catalysed by the KR domain to give a 
p-hydroxy acyl residue. This can then be dehydrated to a 
a-P-unsaturated acyl group by a dehydratase (DH) 
domain and further reduced to a methylene by XADPH 
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Figure 1 
The modular nature of the erythromycin PKS. 
There are six chain extension modules, each 
beginning with a KS domain, that are 
responsible for adding the six successive C, 
units. The loading module specifies 
propionate as starter unit. The completed 
chain is released as a macrolactone by the 
thioesterase (TE) domain. AT, acyl 
s transferase; ACP, acyl carrier protein; KS, 
l=O P-ketoacyl synthetase; KR, f3-ketoacyl 
reductase; ER, enoyl reductase; DH, 
dehydratase. 
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catalysed by an enoyl reductase (ER) domain, The 
extent of reduction in each module of the erythromycin 
PKS can be predicted on the basis of these optional 
domains, which are shown in Figure 1 as ‘reductive 
loops’ set above the line of core domains in each module. 
Only in module 4 is there a complete reductive loop 
leading to complete reduction of the keto group to a 
methylene, whereas in modules 1, 2, 5 and 6, which have 
only an active KR domain, reduction stops at the hydroxy 
stage. In module 3, there is no catalytically active KR 
domain and so no reduction occurs. 
Although analysis of the primary structure of the protein 
allows the function of the various catalytic domains to be 
predicted, no correlation has been established between the 
primary structure of the protein and the stereochemistry of 
the various reactions. Therefore, although it is possible to 
predict with some confidence the structural outcome of 
each chain-extension cycle from the domain structure of a 
module, no prediction can made about the stereochemistry 
of any new chiral centres. 
Celmer noted as early as 1965 that there was a strong 
structural and stereochemical homology between the 
structures of the then-known polyketide macrolides [8]. 
The homology was most marked within the family of 14- 
membered macrolides but it also extended to the families 
of 12- and 16-membered macrolides, if allowance was 
made for the absence of a chain-extension unit or the pres- 
ence of an extra one. The extent and underlying nature of 
these structural relationships can best be appreciated by 
considering the structures of the putative PKS products of 
different biosynthetic pathways. Three representative 
examples are shown in Figure 3. The erythromycin inter- 
mediate shows strong homology to the methymycin inter- 
mediate and also to the tylosin intermediate if allowance 
is made for the absence of methyl-branching centres or 
their replacement by an ethyl branch. This homology 
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Figure 2 
The reactions of a chain-extension cycle 
involving complete reduction of the initially 
formed keto ester to a saturated analogue, and 
the domains that catalyse the various steps. 
Reductive steps; 
optional for polyketides 
C-C Bond formation; 
obligatory step 
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points to a common evolutionary origin for the PKS mul- 
tienzymes serving these biosynthetic pathways. It also 
encourages the hope that the common stereochemical 
features of the natural products might be genetically 
determined and, therefore, that it might be possible to 
make targeted alterations to the genes to produce novel 
products with altered stereochemistry. An understanding 
of the molecular basis of stereocontrol in the biosynthetic 
operations of the PKSs would be of great assistance in 
achieving this goal. 
The earliest speculations concerning the differing stereo- 
chemistries of methyl-branching sites assumed that these 
might be determined by the particular stereoisomer of 
methylmalonate used for chain extension. Both (ZR)- and 
Figure 3 
(ZS)-methylmalonyl-CoA are present in natural systems and 
there are epimerases that can interconvert them [9]. When 
deuterium-labelled precursors were fed to an erythromycin- 
producing strain of Saccharopolyspora erphraea, the pattern 
of label in the macrolide products was consistent with incor- 
poration of (S)-methylmalonyl-CoA followed by condensa- 
tion with inversion of configuration at only three of the six 
methyl-bearing centres, produced by modules 2, 5 and 6 
[lo]. Incorporation levels were very low, however, and no 
conclusion could be drawn concerning the proposed incor- 
poration of the (R) isomer at the remaining three methyl- 
bearing sites produced by modules 1,s and 4. 
The generation of DEBSl-TE, a truncated version of the 
erythromycin PKS, allowed this problem to be addressed 
The putative PKS products of three 
macrolides, methymycin, erythromycin and 
tylosin. Regions of structural and 
stereochemical homology are related by 
colour coding. 
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directly [ll]. DEBSl-TE produces a triketide lactone in 
which the two different stereochemistries at the methyl- 
branching centres are represented (Figure 4). It was found 
that (2X)-methylmalonyl-CoA served as a chain-extension 
building block for both modules, and that the (ZR) isomer 
did not support chain extension [12]. Stereochemical 
control at methyl-branching centres must therefore be 
exerted by the chirality of the chain-extension processes 
themselves, and not by the acyltransferase in each exten- 
sion module that delivers the unit of methylmalonate used 
for chain extension. 
When DEBSl-TE was incubated with (ZS)-methyl- 
malonyl-CoA labelled with deuterium at the methyl- 
bearing chiral centre, it was found that in catalysis by 
module 1 the deuterium was completely lost in forming 
the methyl-branching centre of the first chain-extension 
unit, whereas in catalysis by module 2, it was completely 
retained through the chain-extension reactions [13]. Con- 
densation therefore takes place with inversion of configu- 
ration in module 2 to give the (2R) stereoisomer of the 
fi-keto ester, which is then reduced by KR2 without 
affecting the chiral centre at C-Z to give the (X,3,5’)- 
3-hydroxy-Z-methyl derivative. It was proposed that, in 
module 1, condensation takes place in exactly the same 
sense. and that the (ZR) isomer of the p-keto ester then 
undergoes epimerisation at C-2 with consistent loss of the 
hydrogen label to give the (2s) isomer at that site. l’his is 
then accepted as a substrate and reduced by KRl to give 
the (ZS,3R)-3-hydroxy-Z-methyl diketide intermediate. 
This interpretation suggests that KRl controls the stereo- 
chemistry at both C-2 (by substrate selection) and at G-3 
(by the stereospecificity of hydride addition). The deduc- 
tion that KS1 initially forms the (2R)-isomer of the dike- 
tide ketoester intermediate was confirmed recently by the 
observation that a module can he formed in which KS1 
cooperates with KRZ [14]. The resulting acyl product was 
the (2R,3S)-3-hydroxy-Z-methyl isomer of the diketidc. 
Our aim in this paper is to test these hypotheses by direct 
investigations in a&o on the stereoselectivity of KRl 
towards the (R) and (S’) isomers of the ketoester diketide 
intermediate, and the stereospecificity of the subsequent 
reduction of the keto group. For these experiments we 
used the triketide lactone synthase, DEBSl-TE [ll], and 
a deletion mutant of DEBSl-TE, designated DEBSl-TE 
(AKRZ), in which there is a substantial deletion in the KR 
domain (amino acids 3103-3278 in the conserved region) 
of module 2 (Figure 5). l’he first of these proteins con- 
tains two acti\-e KR domains, KRl and KR2. The second 
protein has only one domain capable of carrying out reduc- 
tion, KRl. The purification of this mutant protein fol- 
lowed the procedure previously developed for 
DEBSl-TE and more detailed investigations of its prop- 
erties will be described in detail elsewhere. Studies with 
the isolated protein in vitro proved that it generated the 
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The modular structure of the truncated DEBS, DEBSl -TE, and its 
synthetic operations. 
predicted kecolactone with the reported nuclear magnetic 
resonance (NMR) spectrum [1.5]. 
Results and discussion 
Choice of substrate 
In its normal context, the ketoester form of the diketide 
remains covalently bound as a thioester to the phospho- 
pantetheine thiol of the ACP during reduction by the 
adjacent KR. To simplify the experimental approach, we 
decided to use a nonenzl-me-bound derivative of the 
ketoester, the ;V-acetyl cysteamine thioester, as a probe of 
the stereocontrol. By analogy. with the use of S-acetoaql- 
NAC thioester as a ketoreductase substrate for a fatty acid 
synthase, it was expected that the reduction product 
would accumulate as its LAC thioester (see Figure 6). 
Synthesis and properties of the NAC thioester derivative of 
the ketoester diketide 
,4n established synthesis was used to prepare the XAC 
derivative of the diketidc ketoester for incubation studies 
[16]. ‘H NMR analysis in D,O showed that the compound 
exists mainly in the keto form (9.5%). The compound is 
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The modular structure of the AKR2 variant of DEBSl -TE and its 
synthetic operations. 
stable to hydrolysis over the time course of a typical incu- 
bation experiment. More significantly, ‘1-I NMR studies in 
D20 solution demonstrated that the H atom at C-Z 
(64.1 ppm) was subject to rapid exchange. This ensures 
that at all stages of an incubation any unreduced ketoester 
would be present as a racemate. 
Preparation and separation of the products of the 
reduction reaction 
All four diastereoisomers of the 3-hydroxy-Z-methyl dike- 
tide intermediate were synthesised by established stereo- 
specific routes [17]. They were also analysed by NhiR and 
characterised by their optical rotation to confirm the rela- 
tive configuration of the two chiral centres. It proved pos- 
sible to analyse mixtures of the four diastereoisomers of 
the NAC derivatives of the hydroxy diketide products by 
high performance liquid chromatography (HPLC) using a 
chiral column. When an equal mixture of the five dike- 
tides (the four P-hydroxy diastereoisomers and the 
P-ketoester starting material) was analysed. peaks being 
detected by the chromophore of the thioester residue 
(232 nm), five almost completely resolved peaks were 
Figure 6 
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The reduction reaction in which the NAC thioester derivative of the 
keto diketide is converted to the hydroxy analogue. 
observed; the peaks for the hydroxy esters were of similar 
intensity. demonstrating that the technique is reliable for 
quantitati\,e analysis of mixtures of the four diastereoiso- 
merit hydroxy products (Figure 7). The detection of the 
ketoester was hindered by its lower extinction coefficient 
and so HPLC was not a sensitive method for monitoring 
turnover. The identity of the four hydroxy ester peaks was 
determined by separate injection of authentic samples of 
each diastereoisomer. The retention times were constant 
within a series of experiments using the same solvent 
mixture. Very slight changes in the concentration of the 
two solvent components resulted in marked variations in 
the retention times and so control injections of the stan- 
dard diketide mixture were carried out with each batch of 
solvent mixture and before each series of experiments. 
A further series of control experiments was carried out with 
synthetic standards to confirm that the efficiency of extrac- 
tion of the four stereoisomers from the buffer used for 
incubation was identical within acceptable limits (+ 10%). 
Reduction catalysed by DEBSl -TE 
First, the NAC derivative of the ketoester was incubated 
with DEBSl-TE, and the rate and extent of reduction was 
measured by consumption of NADPH. as determined by 
IJV absorption at 340 nm. After 30 min, 4% of the 
ketoester had been reduced. The product mixture was 
analysed by chiral HPLC and gave the trace shown in 
Figure 7. The major reduction product is the natural 
hydroxy diketide (ZS’,3R) produced by module 1 of the ery- 
thromvcin PKS (90%) but that there are significant quanti- 
ties (about 10%) of the enantiomer that corresponds to the 
chirality generated in module 2. The molecular composi- 
tion of the compounds giving rise to these peaks was con- 
firmed using high-resolution mass spectrometry. Our 
interpretation of these results is that reduction takes place 
primarily on KRl to give its normal diketide product. The 
small amount of enantiomeric hydroxy ester could be 
formed by reduction of the (S’)-isomer either on KRl with 
altered stereochemical control or more likely on KR2 with 
the normal mode of stcreocontrol. 
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Figure 7 
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Chiral HPLC analysis of the NAC-thioester derivatives of the four 
stereoisomers of the erythromycin diketide. (a) The products isolated 
from incubation of the ketoester with DEBSl -TE (AKRZ). (b) The 
products isolated from incubation of the ketoester with DEBSl -TE. 
(c) An equimolar mixture of the keto analogue and the four 
diastereoisomers of the hydroxy dervative. Note: the retention times of 
all the diastereometric hydroxy esters varied in the same direction and 
to approximately the same extent by up to 20%, depending on the 
current batch of eluting solvent. The HPLC traces shown in (a) and (b) 
have been aligned with that shown in (c) in the interests of clarity. In all 
cases, the current retention times were calibrated by control injections 
with synthetic standard samples. mA U, milliabsorbance units. 
Reduction reaction using DEB% -TE (AKRZ) 
This ambiguity was resolved by repeating the experi- 
ment using the AKR2 mutant version of DEBSl-TE. In 
this case, the only product detected by chiral HPLC was 
the normal hydroxy diketide product of module 1 
(Figure 7). KRl is, therefore, entirely stereoselective 
towards its substrate in that it accepts the (28) isomer 
and rejects the (2%) isomer, both of which are present in 
the racemic form of the starting material present in the 
incubation mixture. After selection of the required 
stereoisomer of the ketoester, reduction proceeds stere- 
ospecifically at C-3 to give the normal (2S,3R) product. 
We further conclude that the minor diastereoisomer pro- 
duced by DEBSl-TE is the product of reduction by 
KRZ, which accepts the enantiomeric ketoester as a sub- 
stitute for its normal structurally different substrate (the 
(ZR)-triketide analogue). We cannot draw from these 
results, however, any further conclusion concerning the 
stereoselectivity and stereospecificity of KR2 because a 
small proportion of the major product might also have 
been formed by this domain. 
The demonstration that KRl is both stereoselective and 
stereospecific in reducing the ketoester diketide intermedi- 
ate confirms earlier predictions concerning the control of 
stereochemistry during product formation in module 1 of 
the erythromycin PKS. In its normal context, KRl selects 
between the two epimers of the enzyme-based ketoester 
and then carries out its reduction stereospecitically. It 
therefore controls the C-Z stereochemistry indirectly and 
the C-3 centre directly. Control of chirality in the two chiral 
centres generated by this module is. therefore, exerted 
exclusively by the ketoreductase domain, KRI. 
The mechanism of control in module 2 is not yet fully 
defined. Epimerisation of the methyl centre is not 
observed, but there are two possible explanations for this 
omission. First, it might be that there is no potential 
epimerisation activity in that module and therefore that 
KR2 has no choice over substrate selection. In this case, 
KS2 determines the chirality at C-Z. Alternatively, an 
epimerase activity might be present, but is overwhelmed 
in this module by the dominant reductase activity of KRZ, 
which recognises and removes the (2R) isomer as its sub- 
strate before epimerisation can occur. 
Significance 
Polyketides, a large family of compounds that possess 
medicinally important activities, are synthesised by large 
multienzyme complexes called polyketide synthases 
(PKSs). The modular nature of the PKSs has attracted 
much attention because of the potential for bioengineer- 
ing new complexes that generate novel polyketides. An 
understanding of the factors that control the configura- 
tion of chiral centres during polyketide assembly on 
PKSs is crucial for rational genetic engineering of these 
molecular assembly lines. 
We have shown here that a ketoreductase (KR) domain 
can exert control over stereochemistry, not only at the 
newly formed C-3 hydroxy centre, where hydride addi- 
tion takes place, but also at the adjacent methyl-bearing 
centre at C-2, by selection of the appropriate diastereo- 
isomer of the 3-ketoacyl intermediate. 
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This result confirms that there are two different mecha- 
nisms of stereochemical control working in modules 1 
and 2 of the erythromycin PKS. The difference hinges 
on the existence of an epimerisation activity towards the 
P-ketoester intermediate in module 1 but not in module 2. 
It is possible that further variations on the mechanisms 
of stereochemical control operate in other modules of 
polyketide synthases generally. The methods of investi- 
gation described here could be more widely applied to 
examine this possibility. 
Materials and methods 
Exchange of the a-hydrogen of the P-keto diketide NAC 
NMR spectra in H,O and D,O were run in 2 ml buffered solutions 
(400 mM potassium phosphate, pH 7) containing the NAC thioester of 
the P-keto diketide (2 mg). The spectrum in Hz0 was acquired with 
water suppression via a presaturation microprogram. 6, (400 MHz, 
H,O): 4.1 (lH, q, J 7 Hz), 3.3 (2H, q, J7Hz), 3.0, (2H, m), 2.6 (2H, 4m), 
1.9 (3H, S), 1.3 (3H, d, J 7Hz), 1.0 (3H, q, J 7Hz). In the spectrum run 
on a D,O solution the peak at 64.1 disappeared and the doublet at 
6 1.3 was replaced by a singlet. 
Reduction reaction assays 
Either DEBSl -TE (400 pg/ml) or DEBSl -TE (AKRP) (478 ug/ml), in 
400 mM potassium phosphate buffer, pH 7.0, containing EDTA (1 mM) 
was incubated for 30 min, at 30°C with NADPH and the NAC deriva- 
tive of the P-keto diketide. For DEBSl-TE, a final concentration of 
2 mM of NADPH and of the NAC derivative of the P-keto diketide was 
used. For the AKR2 protein, a final concentration of 2.8 mM for each 
substrate was used. The total volume was 1 ml for DEBSl-TE and 
0.4 ml for DEBSl -TE (AKR2). The ketoreduction reaction was followed 
at 340 nm using a Shimadzu UV-2100 spectrophotometer. The quartz 
cuvettes used were a matched pair with a 1 mm path length. The prod- 
ucts were isolated after 30 min. 
Detection of the products of the reduction reaction using HPLC 
The reaction products were extracted using ethyl acetate (3 x 100 pl) 
and after removal of the solvent in vacua, were resuspended in 7% 
ethanol in iso-hexane (Fisons, HPLC-grade). The product mixture was 
then analysed by HPLC, using a Hewlett-Packard 1090 HPLC instru- 
ment fitted with a Chiralcel OC column (Diacel, 25 cm x 4.6 mm, guard 
column 5 cm x 4.6 mm). Compounds were eluted at 1 ml/min in 7% 
ethanol in iso-hexane. Control samples were run before each batch of 
analyses to determine the standard retention times using the current 
batch of solvent mixture. 
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